Nikko Asset Management Americas’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-504,201
| Closed | -$37.7M | – | 229 |
|
2021
Q1 | $37.7M | Buy |
504,201
+66,002
| +15% | +$4.94M | 0.18% | 88 |
|
2020
Q4 | $47.5M | Buy |
438,199
+19,964
| +5% | +$2.17M | 0.27% | 76 |
|
2020
Q3 | $36.3M | Sell |
418,235
-53,124
| -11% | -$4.61M | 0.32% | 64 |
|
2020
Q2 | $38.9M | Sell |
471,359
-21,162
| -4% | -$1.75M | 0.51% | 50 |
|
2020
Q1 | $29.2M | Sell |
492,521
-4,945
| -1% | -$293K | 0.54% | 49 |
|
2019
Q4 | $34.4M | Buy |
497,466
+34,089
| +7% | +$2.36M | 0.54% | 52 |
|
2019
Q3 | $48.1M | Buy |
463,377
+164,601
| +55% | +$17.1M | 0.85% | 38 |
|
2019
Q2 | $27.7M | Buy |
298,776
+230,328
| +337% | +$21.3M | 0.54% | 48 |
|
2019
Q1 | $6.26M | Buy |
68,448
+68,246
| +33,785% | +$6.24M | 0.17% | 96 |
|
2018
Q4 | $11K | Sell |
202
-3
| -1% | -$163 | ﹤0.01% | 145 |
|
2018
Q3 | $25K | Buy |
+205
| New | +$25K | ﹤0.01% | 144 |
|